ICOSIM Weekly – 22 May 2026

Dear colleagues,

This week, I am especially proud to share something that reflects how far our community has come: dentists and physicians from abroad are travelling to Munich to study clinical osteoimmunology at its source.

Munich Osteoimmunology Experience — International Immersion

It is my pleasure to share the Munich Osteoimmunology

Experience — an advanced four-day immersion in Munich,

Germany, on May 24–27, 2026.

This is a rare opportunity to work directly at the origin of the FDOJ

protocol. Over four intensive days, participants apply the three

diagnostic tools I have developed across four decades —

CaviTAU®, MindLINK® and OroTox® — alongside the Jawbone

Detox® concept, through evidence-based protocols and hands-on clinical workflows.

Taught in English with live Portuguese interpretation, coordinated by

Dra. Regeane Kaniak, and concluding with international ICOSIM

certification.

This is an intimate cohort, and we currently have only 2 places

remaining. If you would like to join — or know a colleague who would value this experience — I would be glad to hear from you.

Dr. Dr. (PhD) Johann Lechner

in collaboration with Dra. Regeane Kaniak

Mit kollegialem Gruß und der Bitte unsere Seminar und Webinar Ankündigungen zu beachten verbleibe ich!

Bis zum nächsten ICOSIM-Weekly, 

Euer Hans Lechner

Grünwalder Straße 10a

81547 München

GERMANY 

T: +49 89 244 17 997
F: +49 89 244 15 44 69

ICOSIM® e.V. eingetragener Verein beim Amtsgericht München

Vertreten durch Dr. Dr. (PhD-UCN) Johann Lechner, Robert Huber
Sitz der Grünwalderstr. 10a; 81547 München | VR 205811

VERTRAULICHKEITSHINWEIS: Der Inhalt dieser E-Mail ist vertraulich und ausschließlich für den bezeichneten Adressaten bestimmt. Wenn Sie nicht der vorgesehene Adressat dieser E-Mail oder dessen Vertreter sein sollten, so beachten Sie bitte, dass jede Form der Veröffentlichung, Vervielfältigung oder Weitergabe des Inhaltes dieser E-Mail unzulässig ist. Bitte setzen Sie sich mit dem Absender der E-Mail in Verbindung. 

CONFIDENTIALITY NOTICE: This e-mail message (including all attachments) is for sole use of the intended recipient(s) and may contain confidential and/or privileged information. Any unauthorised review, use, disclosure, copying or distribution is strictly prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message. We do not accept any responsibility for damages caused anyhow by viruses transmitted via email.

P Think before you print.